DK1069902T3 - Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsioner - Google Patents

Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsioner

Info

Publication number
DK1069902T3
DK1069902T3 DK98955792T DK98955792T DK1069902T3 DK 1069902 T3 DK1069902 T3 DK 1069902T3 DK 98955792 T DK98955792 T DK 98955792T DK 98955792 T DK98955792 T DK 98955792T DK 1069902 T3 DK1069902 T3 DK 1069902T3
Authority
DK
Denmark
Prior art keywords
adhesions
phospholipids
drug
prevention
manufacture
Prior art date
Application number
DK98955792T
Other languages
Danish (da)
English (en)
Inventor
Brian Andrew Hills
Derek Alan Woodcock
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK1069902T3 publication Critical patent/DK1069902T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK98955792T 1998-04-03 1998-11-26 Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsioner DK1069902T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9807298.6A GB9807298D0 (en) 1998-04-03 1998-04-03 Medicament
PCT/GB1998/003540 WO1999051244A1 (en) 1998-04-03 1998-11-26 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions

Publications (1)

Publication Number Publication Date
DK1069902T3 true DK1069902T3 (da) 2004-06-07

Family

ID=10829890

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98955792T DK1069902T3 (da) 1998-04-03 1998-11-26 Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsioner

Country Status (12)

Country Link
US (1) US6719960B1 (enExample)
EP (1) EP1069902B1 (enExample)
JP (1) JP4287050B2 (enExample)
AT (1) ATE259234T1 (enExample)
AU (1) AU1251799A (enExample)
CA (1) CA2327693C (enExample)
DE (1) DE69821655T2 (enExample)
DK (1) DK1069902T3 (enExample)
ES (1) ES2214748T3 (enExample)
GB (2) GB9807298D0 (enExample)
PT (1) PT1069902E (enExample)
WO (1) WO1999051244A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807298D0 (en) 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
WO2002094283A2 (en) * 2001-05-21 2002-11-28 Britannia Pharmaceuticals Limited Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs
GB0115505D0 (en) * 2001-06-25 2001-08-15 Britannia Pharmaceuticals Ltd Prevention of surgical adhesions
GB0200704D0 (en) * 2002-01-14 2002-02-27 Britannia Pharmaceuticals Ltd Use of phospholipids in peritoneal dialysis
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
EP1426053A1 (en) * 2002-12-03 2004-06-09 Fresenius Kabi Deutschland GmbH Use of amphiphilic lipids for reducing tumor metastasis
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
ES2336796T3 (es) 2003-10-07 2010-04-16 Northgate Technologies Incorporated Sistema para suministrar una sustancia a una cavitacion corporal.
EP1680173B1 (en) * 2003-10-31 2011-01-12 Trudell Medical International System for manipulating a catheter for delivering a substance to a body cavity
GB0426010D0 (en) * 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
CA2660050A1 (en) 2006-08-04 2008-02-07 Northgate Technologies Inc. In-dwelling port for access into a body
US8020726B1 (en) * 2006-10-18 2011-09-20 Sandia Corporation Powder dispersion system
US20080241270A1 (en) * 2007-03-30 2008-10-02 Neal Robert A Fluid composition for inhibiting surgical adhesion formation and related method of production
US9572595B1 (en) 2014-03-05 2017-02-21 Northgate Technologies Inc. In-dwelling port for access into a body
GB201511058D0 (en) * 2015-06-23 2015-08-05 Lamellar Biomedical Ltd Compositions and methods for using lamellar bodies for therapeutic purposes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58164513A (ja) * 1982-03-25 1983-09-29 Teijin Ltd 肺表面活性物質及びその調製法
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
IN166447B (enExample) * 1985-11-27 1990-05-12 Ethicon Inc
WO1991012026A1 (en) * 1990-02-14 1991-08-22 Macnaught Pty Limited Means of reducing surgical adhesions
CA2083171C (en) 1990-05-18 2002-09-10 Kurashima Kazuyoshi Antasthmatic
US5438044A (en) * 1992-06-30 1995-08-01 Rhone-Poulenc Rorer Phospholipid composition
AU7685798A (en) 1997-05-29 1998-12-30 Applied Biotechnologies Inc. Compositions and methods for preventing adhesion
GB9807298D0 (en) 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament

Also Published As

Publication number Publication date
PT1069902E (pt) 2004-06-30
JP4287050B2 (ja) 2009-07-01
ATE259234T1 (de) 2004-02-15
GB2335853A (en) 1999-10-06
DE69821655T2 (de) 2004-12-23
CA2327693A1 (en) 1999-10-14
GB9825971D0 (en) 1999-01-20
GB9807298D0 (en) 1998-06-03
JP2002510638A (ja) 2002-04-09
AU1251799A (en) 1999-10-25
EP1069902A1 (en) 2001-01-24
EP1069902B1 (en) 2004-02-11
WO1999051244A1 (en) 1999-10-14
CA2327693C (en) 2006-11-21
US6719960B1 (en) 2004-04-13
ES2214748T3 (es) 2004-09-16
DE69821655D1 (de) 2004-03-18

Similar Documents

Publication Publication Date Title
DK1069902T3 (da) Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsioner
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
DE69931159D1 (de) Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
DE60143889D1 (de) Parasiticide formulierung und methode zur herstellung dieser formulierung
ES2194050T3 (es) Uso de bisfosfonatos para inhibir la resorcion osea tras la implantacion de una protesis osea.
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
SE9704644D0 (sv) New use
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
EA200000176A1 (ru) Применение физиологически приемлемых соединений, солей и комплексов ванадия
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
ID27083A (id) Komposisi farmasi untuk pencegahan dan pengobatan penyakit-penyakit yang behubungan dengan sitopati jaringan okuler fundus
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
GEP20043231B (en) Resorcinol Composition
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
DK1049468T3 (da) Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår
AR011707A1 (es) Composicion farmaceutica que comprende tirosina y un alergeno opcionalmente modificado, procedimiento para su preparacion y el uso de la misma para la manufactura de un medicamento.